Doximity (DOCS) & Its Rivals Head to Head Contrast

Doximity (NYSE:DOCS) is one of 93 public companies in the “Healthcare Technology” industry, but how does it contrast to its competitors? We will compare Doximity to related businesses based on the strength of its dividends, institutional ownership, earnings, valuation, analyst recommendations, profitability and risk.

Profitability

This table compares Doximity and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Doximity	25.48%	18.06%	15.40%
Doximity Competitors	-778.92%	-33.96%	-15.64%

Analyst Recommendations

This is a summary of recent ratings for Doximity and its competitors, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Doximity	3	14	8	0	2.20
Doximity Competitors	447	1517	2725	88	2.51

Doximity presently has a consensus price target of $30.73, suggesting a potential downside of 7.18%. As a group, “Healthcare Technology” companies have a potential upside of 42.19%. Given Doximity’s competitors stronger consensus rating and higher probable upside, analysts plainly believe Doximity has less favorable growth aspects than its competitors.

Earnings & Valuation

This table compares Doximity and its competitors top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Doximity	$644.86 million	$196.05 million	38.95
Doximity Competitors	$342.33 million	-$24.15 million	12.89

Doximity has higher revenue and earnings than its competitors. Doximity is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.

Volatility and Risk

Doximity has a beta of 1.29, meaning that its stock price is 29% more volatile than the S&P 500. Comparatively, Doximity’s competitors have a beta of 1.14, meaning that their average stock price is 14% more volatile than the S&P 500.

Insider & Institutional Ownership

87.2% of Doximity shares are held by institutional investors. Comparatively, 42.3% of shares of all “Healthcare Technology” companies are held by institutional investors. 31.8% of Doximity shares are held by insiders. Comparatively, 16.0% of shares of all “Healthcare Technology” companies are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Doximity beats its competitors on 9 of the 13 factors compared.

Doximity Company Profile

Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company’s cloud-based platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical companies and health systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.